NIH-funded research R21 grant

Exploring how different forms of α-synuclein fibrils affect brain diseases

Official title: Investigating the interplay between polymorphic α-syn fibril conformation and cell-dependent pathology

Funded at Drexel University · NIH-10951926 · Data updated 2026-11-12

This study is looking at how different types of a protein called α-synuclein might affect brain cells in conditions like Lewy body dementia, Parkinson's disease, and multiple system atrophy, using special technology to mimic a real brain environment, so we can better understand how these diseases progress.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDrexel University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$414,191
NIH project number1R21NS139178-01
Project IDNIH-10951926 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Lewy body dementia, Parkinson's disease, or multiple system atrophy.

Less likely to help

Patients with other neurodegenerative diseases not related to synucleinopathies may not benefit from this research.

What this research studies

This research investigates the relationship between various forms of α-synuclein fibrils and their role in diseases like Lewy body dementia, Parkinson's disease, and multiple system atrophy. By using advanced techniques such as human organ-on-a-chip technology, the study aims to understand how these fibrils interact with different cell types in the brain. The research will produce and analyze different α-synuclein fibril structures to see how they contribute to disease progression in a realistic brain environment. This approach could help clarify the mechanisms behind these neurodegenerative diseases.

Why it matters

Potential benefit: If successful, this research could lead to better diagnostic tools and targeted therapies for patients with synucleinopathies.

How similar studies have gone: Previous research has shown promising results in understanding amyloid fibrils in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Drexel University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Lee, Myungwoon — Drexel University
  • Study coordinator: Lee, Myungwoon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.